Thioctic acid is widely used in clinical treatment of diabetic peripheral neuropathy. The human bioequivalence (BE) study of thioctic acid tablet should follow the relevant regulations and guidelines, and fully consider the particularity of the clinical use of this product. It is recommended to adopt a single dose, two preparations, two sequences, partial or complete repeated crossover study design, and select the reference preparations that have been publicly released for the fasting test. In addition, researchers should pay attention to the Chinese version of The Internationevl Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) M13A and its Q&A document, as well as the BE study ideas of similar drugs. This article takes the BE study of thioctic acid tablet as an example to provide in-depth guidance for the research.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |